Yan Ming

CHIEF TECHNOLOGY OFFICER, DirectorCytek Biosciences, Inc. (CTKB) · full profile →Form 4 · filed Mar 19, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$270K
Net Open-Market Flow
-$270K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 19, 2024Sell(S)20K$6.71$134K6.0M
Mar 18, 2024Sell(S)20K$6.77$135K6.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-008641) within minutes of acceptance. Every field above traces to the original document. Verify it directly: